Full-Time

Director – Endocrinology Payer and Patient Support Program

Psp, Marketing

Confirmed live in the last 24 hours

Corcept Therapeutics

Corcept Therapeutics

201-500 employees

Develops cortisol modulators for medical conditions

Biotechnology
Healthcare

Compensation Overview

$232.8k - $273.8kAnnually

Senior, Expert

San Carlos, CA, USA

Category
General Marketing
PR & Communications
Growth & Marketing
Required Skills
Market Research
Marketing
Data Analysis

You match the following Corcept Therapeutics's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • Strategic mindset and patient centric approach to the business
  • Endocrinology payer marketing experience
  • Ability to thrive in a fast-paced environment
  • Effective communication skills and ability to engage all levels of the organization including at the C-Suite level
  • Working knowledge of US health care policies and relevant legal, compliance, regulatory requirements
  • Some travel required, including trips to key customer and association meetings
Responsibilities
  • Partner with the market access leadership, the HEOR/RWE team and the endocrinology brand team to develop and execute the payer coverage strategy for Part D and commercial payers
  • Responsible for, in collaboration with the HEOR/RWE team, payer value resources to support payer coverage
  • Partner with marketing and market research planning to create resources and programs to support adoption and patient access
  • Collaborate with senior leadership to align access initiatives with corporate goals
  • Develop marketing materials to promote the program to HCPs and patients to support a positive patient and provider experience with a new therapy
  • Analyze product volume, trends, and growth, for assigned accounts
  • Collaborate with account teams to develop and implement account level business plans and to gain insights and input into development of programs and tactics
Desired Qualifications
  • Education: Bachelor’s Degree
  • 8+ years of pharmaceutical or healthcare industry experience
  • Endocrinology experience highly desirable
  • 2-3 years of market access marketing experience
  • Managed markets account management experience preferred
  • Brand marketing experience preferred

Corcept Therapeutics focuses on developing treatments that regulate cortisol levels in the body, which is important for managing stress, metabolism, and immune functions. Their main product, Korlym, is the first FDA-approved treatment for Cushing's syndrome, a condition caused by excessive cortisol. The company has discovered over 1,000 selective cortisol modulators and aims to expand its offerings with new treatments in development. Unlike many competitors, Corcept emphasizes both research and patient education, providing resources to healthcare professionals and patients to improve understanding and care for cortisol-related disorders. The goal of Corcept is to lead in cortisol modulation therapies and enhance the quality of life for patients suffering from conditions related to cortisol imbalance.

Company Stage

IPO

Total Funding

$39.7M

Headquarters

Menlo Park, California

Founded

1998

Growth & Insights
Headcount

6 month growth

3%

1 year growth

2%

2 year growth

-3%
Simplify Jobs

Simplify's Take

What believers are saying

  • Increased interest in cortisol therapies for mental health boosts Corcept's R&D prospects.
  • Advancements in drug delivery systems could enhance Corcept's product efficacy.
  • The FDA's fast-track designation supports Corcept's innovative cortisol-related treatments.

What critics are saying

  • Teva's antitrust lawsuit could lead to legal expenses and market share loss.
  • Heavy reliance on Korlym makes Corcept vulnerable to market fluctuations.
  • Recent investments may pressure Corcept for short-term financial performance, impacting R&D.

What makes Corcept Therapeutics unique

  • Corcept specializes in cortisol modulation, a niche with few direct competitors.
  • Korlym is the first FDA-approved treatment for Cushing's syndrome, a significant market advantage.
  • Corcept's extensive R&D has led to the discovery of over 1,000 selective cortisol modulators.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Flexible Work Hours